Potential use of human interleukin 2 as an adjunct for the therapy of neoplasia, immunodeficiency and infectious disease
| Autor: | Vincent J. Merluzzi, Kathleen Last-Barney |
|---|---|
| Rok vydání: | 1985 |
| Předmět: |
Interleukin 2
medicine.medical_treatment Immunology Infections Mice Immunity In vivo Neoplasms medicine Animals Humans Immunodeficiency Bone Marrow Transplantation Pharmacology Clinical Trials as Topic Immunity Cellular business.industry Immunologic Deficiency Syndromes Lymphokine Immunotherapy medicine.disease Killer Cells Natural Clinical trial stomatognathic diseases Infectious disease (medical specialty) Interleukin-2 business medicine.drug |
| Zdroj: | International Journal of Immunopharmacology. 7:31-39 |
| ISSN: | 0192-0561 |
| DOI: | 10.1016/0192-0561(85)90006-2 |
| Popis: | Experimental and clinical systems have been developed to analyze both the in vitro and in vivo effects of highly purified interleukin 2 (IL2) as a potential therapeutic adjunct for neoplasia, immunodeficiency and infectious disease. Animal models, clinical in vitro studies, as well as preliminary clinical trials of IL2 in vivo show that this lymphokine may provide a necessary signal for the activation of thymus-derived T cells in immunologically-compromised hosts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|